Results 161 to 170 of about 38,655 (210)

A Rare Case of Bullous Pemphigoid Triggered by Overlapping Immune Dysregulation From HIV and Hodgkin Lymphoma: A Case Report. [PDF]

Cureus
Palacio I, Arraut K, Portalatin K, Estil-Las AA, Grace M.   +4 more
europepmc   +1 more source

Bullous Cutaneous Lesions in Pediatrics: A Diagnostic Challenge. [PDF]

Clin Pediatr (Phila)
Medina Bethencourt M, José García Díaz F, Andrade Díaz C, Lanero Olivencia B, Martínez Carapeto I.   +4 more
europepmc   +1 more source

Disseminated Erythema and Vesicles on the Trunk and Extremities in a Teenager: A Quiz. [PDF]

Acta Derm Venereol
Zhao C, Wang H, Wang L.
europepmc   +1 more source

Effectiveness and safety of methylprednisolone combination with abrocitinib compared to methylprednisolone combination with azathioprine in bullous pemphigoid: a retrospective study. [PDF]

Sci Rep
Chen Y, Zhuang Z, Mao J, Bao S, Zhang Y, Wu Z, Chen W, Tong Z, Gong T, Ji C.   +9 more
europepmc   +1 more source

Erythroderma and Bullae in a Psoriatic Patient: Navigating Diagnostic Bias. [PDF]

Cureus
Nadelmann JR, Nadelmann ER, Halverstam C, Wu B.   +3 more
europepmc   +1 more source

Real-Time, Noninvasive Diagnosis of Bullous Pemphigoid: Diagnostic Performance of Line-Field Confocal Optical Coherence Tomography. [PDF]

Skin Res Technol
Gellrich FF, Rakhmetova S, Günther C, Beissert S, Hobelsberger S.   +4 more
europepmc   +1 more source

Rituximab-Based Management of Autoimmune Blistering Diseases: A Case Series Highlighting Ocular and Systemic Presentations. [PDF]

Cureus
Vázquez-Folch SJ, Jiménez-Berríos GA, Vazquez VJ, Izquierdo N.   +3 more
europepmc   +1 more source

Hematological inflammatory biomarkers as predictors of the severity and outcomes of bullous pemphigoid: A retrospective cohort study. [PDF]

JAAD Int
Chen HH, Huang PW, Cho YT, Chu CY.
europepmc   +1 more source

The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies. [PDF]

Int J Mol Sci
Pala V, Rosset F, Mastorino L, Sciamarrelli N, Boskovic S, Borriello S, Bongiovanni E, Crespi O, Ribero S, Quaglino P.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Evaluation of Dupilumab in Patients With Bullous Pemphigoid.

JAMA dermatology, 2023
Importance Dupilumab is a theoretically novel therapy for bullous pemphigoid (BP). However, its effectiveness and safety have yet to be confirmed in a large-scale study.
Liuqi Zhao, Qijun Wang, Gui-Juan Liang, Yuxi Zhou, Nam Yiu, Baoqi Yang, Guiying Zhang, W. Li, S. Feng, Panpan Shang, Xixue Chen, Xuejun Zhu, Jie Zheng, M. Pan, Mingyue Wang   +14 more
semanticscholar   +1 more source